Experimental Clinical studies Flashcards

1
Q

Draw a table suggesting the likelihood of problems with each of the main three types of studies. Include Bias, Confounding and Random Error

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Give four examples of suitable treatments to test using a RCT, and 2 that would be more difficult.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Name 5 key useful features an RCT could have to ensure accuracy.

A

Controlled (placebo controlled)
Randomized
Double blind
Large
Analysed by `intention to treat’ method

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Name 3 common reasons a patient’s condition can improve in the absence of a specific treatment.

A

Natural tendency to recover –> biological healing and repair (especially with good nursing care)

Probability – individuals at the extreme of a distribution tend to come towards the mean - `regression to the mean’

The placebo effect – when people believe that they are receiving a treatment (even if actually neutral) their recovery is improved

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why is it not advisable to use a control group of historical case?

A

Because outcomes often change (tend to improve) with time….

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are three different options of how to treat your control group?

A

CONTROL groups –

  1. Receiving no active treatment
  2. Receiving USUAL CARE (i.e. existing pattern of treatment, but without the new intervention being tested)
  3. Either of these categories can also be receiving PLACEBO for the active intervention under test
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Outline the importance of randomisation within the allocation process. Specifically which type of bias does it directly inhibit?

A

The best way of ensuring that the characteristics of patients in the INTERVENTION and CONTROL groups are similar

Specifically avoids allocation bias

Indirectly avoids…

Selection bias and confounding (problem in CCS and CS) are excluded if the study is well designed

Randomization also facilitates the process of `blinding’ which reduces the risk of information bias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the difference between Selection and Allocation Bias?

A

Selection bias occurs if the selected sample is not representative of the patient population.

If there is a systematic difference between participants in how they are assigned to treatment groups, then it is referred to as Allocation Bias.

This is minimised by the use of random allocation.

NB: The randomisation of patients to treatment groups will not affect selection bias.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Why is blinding important to the assessment process in an RCT?

A
  • There are always vested interests in the outcome of trial!
  • Objective outcomes (e.g. death) are pretty robust, however problems with subjective, patient assessed outcomes (`I feel so much better on this new treatment doctor…’) can lead to – ASSESSMENT BIAS
  • This can also happen with observer assessed outcomes (e.g. reported `health’, blood pressure) – ASSESSMENT BIAS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Explain the difference between a Single, Double and Triple Blind study

A

Patient OR outcome assessor blind = single blind

Patient AND outcome assessor blind = double blind

Patient + outcome assessor + statistician = triple blind

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are two options to minimise assessment bias if the study is not Triple Blind?

A
  • Statistician can carry out analysis blind to randomisation code
  • Trial analyses are pre-specified in great detail, then less need for blinding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is a crossover study? And what are it’s advantages?

A

Crossover Study

A longitudinal study in which subjects receive a sequence of different treatments (or exposures).

Nearly all crossover are designed to have “balance”, whereby all subjects receive the same number of treatments and participate for the same number of periods.

In most crossover trials each subject receives all treatments, in a random order.

Advantages

  • Very efficient trial design because every participant acts as both intervention and control
  • For a given number of participants, get a more precise estimate of effect than with parallel group
  • Only works for RAPIDLY ACHIEVED and REVERSIBLE outcomes (e.g blood pressure)
  • NOT for irreversible events (e.g development of cancer, diabetes, death)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a factorial study?

A

Involves 2 interventions (e.g. blood pressure lowering A and lipid lowering treatments B)

4 equal sized randomized groups

  • None (control group)
  • A
  • B
  • A + B (dual intervention)

Efficient design, because all groups involved in examining both the effect of A and the effect of B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is a type 2 error?

A

A type II error is a statistical term used within the context of hypothesis testing that describes the error that occurs when one accepts a null hypothesis that is actually false. A type II error produces a false negative, also known as an error of omission.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the advantages of a larger sample size?

A
  • Higher statistical power (likelihood of detecting a true intervention effect when present)
  • More precise estimate of effect size
  • Ability to look at the impact of the intervention in a range of different subgroups (different age-groups, genders, disease characteristics)

N.B. Does NOT make trial more representative of the population at large (that depends on the source of the trial population)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are three important ethical assumptions that patients expect when entering a trial?

And how can these ethical considerations be upheld?

A

Presumption that patients entering trials…

  • Will not come to harm
  • Will not be excluded from usual effective Rx
  • Will be fully informed re prospects of benefit/risk

Implications in practice

  • Intervention must be likely to benefit rather than harm
  • Control group – focus on usual care (not no care)
  • Proper informed consent procedures
  • Monitoring (and reporting) safety, adverse effects
17
Q

What is a null hypothesis?

A

The presumption of no difference between intervention and control groups in outcome

18
Q

Give an example of a Continuous vs a Categorical outcome

A

Continuous

  • e.g. blood glucose, blood pressure

(mean difference)

Categorical

  • e.g. event/no event
    • Dead or alive?
    • MI / No MI
19
Q

What would a 95% confidence interval indicate?

A

A 95% confidence interval is a range of values that you can be 95% certain contains the true mean of the population

20
Q

What is the difference between an ‘Intention to Treat’ and a ‘Per Protocol’ analysis?

A

Intention to treat analysis

  • Carries out the analysis on the basis of original randomisation, so ignores crossovers
  • Is likely to underestimate effect of intervention (depending on how much `crossover’ took place)
  • UNBIASED estimate of intervention effect
  • Should be main analysis presented in most situations

Per protocol analysis

  • Carries out the analysis on the basis of the treatment actually taken, so takes crossover between groups into account
  • Less likely to underestimate effect of intervention
  • BIASED estimate of intervention effect (exactly how depends on number and characteristics of drop-outs)
  • Should generally be a subsidiary analysis

N.B: Patients crossover between the control/intervention groups normally for the following two reasons:

  • Some control patients will end up being on treatment (often most severely ill)
  • Some intervention patients will end up coming off active treatment (often most severely ill)
21
Q

What is the difference between Cost-benefit and Cost-effectiveness?

A
  • Cost-benefit (how much does cost to `save a life’ using this treatment?)
  • Cost-effectiveness (cost of benefit compared with other clinical interventions)
22
Q

What is the difference between a High Risk and Population strategy in epidemiologcal approaches to public health?

A

The main difference between strategies is who is the focus of the intervention.

The high-risk strategy is generally implemented to decrease risk or course of disease among those with the greatest potential burden

The population strategy seeks to maximse the number of individuals reached by an intervention, with less concern for the differential risk that individuals face in developing disease.